Giant Cell Myocarditis: An Updated Review of Pathogenesis, Clinical Presentation, and Modern Management Approaches

Area of Science:

• Cardiology
• Immunology
• Pathology

Background:

• Giant cell myocarditis (GCM) is a rare, aggressive cardiac disorder.
• It presents with diverse symptoms mimicking other inflammatory heart conditions, complicating diagnosis.
• GCM can lead to rapid cardiac deterioration and poor patient outcomes.

Purpose of the Study:

• To review the clinical presentation of GCM.
• To outline diagnostic strategies and differentiate GCM from cardiac sarcoidosis.
• To discuss current and emerging therapeutic options for GCM.

Main Methods:

• Literature review of clinical presentations, diagnostic modalities, and treatment strategies for GCM.
• Emphasis on comparing diagnostic features with cardiac sarcoidosis.
• Analysis of outcomes and recurrence rates.

Main Results:

• GCM symptoms overlap with other inflammatory cardiac conditions, posing diagnostic challenges.
• Cardiac MRI and PET can show inflammation but are not definitive.
• Endomyocardial biopsy is the gold standard, revealing giant cells and myocyte necrosis.
• Immunosuppressive therapy is the cornerstone of management.
• Many patients require mechanical support or transplantation despite treatment.

Conclusions:

• Early diagnosis of GCM is critical for timely intervention.
• Distinguishing GCM from cardiac sarcoidosis requires a comprehensive approach.
• Prompt immunosuppression and management of cardiac complications improve outcomes.
• Despite treatment, advanced therapies like transplantation may be necessary, with a risk of recurrence.